Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000490211 | SCV000576777 | uncertain significance | not specified | 2017-04-19 | criteria provided, single submitter | clinical testing | The I348K variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The I348K variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The I348K variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is not conserved. In silico analysis predicts this variant is probably damaging to the protein structure/function. In summary, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Mayo Clinic Laboratories, |
RCV004791496 | SCV005411868 | uncertain significance | not provided | 2024-01-10 | criteria provided, single submitter | clinical testing | PM2 |
Natera, |
RCV001276453 | SCV001462818 | uncertain significance | Renal carnitine transport defect | 2020-09-16 | no assertion criteria provided | clinical testing |